Impact Analysis of Covid-19 The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters. Request Sample

Surgical stapling devices can be defined as the staplers which are used in surgical procedures in order to seal or close the wound or the incised portion of the body. These are specialized instruments that can be used to seal or close the both internal as well as external wounds.

Statistics:

The global surgical stapling devices market is estimated to account for US$ 4,364.6 Mn in terms of value by the end of 2027.

Global Surgical Stapling Devices Market: Drivers

Increasing prevalence of obesity is expected to propel growth of the global surgical stapling devices market over the forecast period. For instance, according to the Centers of Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2018, 71424.3 thousand people in the U.S. suffer from obesity.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Statistics:

North America held dominant position in the global surgical stapling devices market in 2019, accounting for 28.6% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Surgical Stapling Devices Market Share (%) Value, By Region, 2019





Global Surgical Stapling Devices Market: Restraints

Use of surgical stapling devices can lead to injury after removing stapler, which is expected to hinder the market growth. For instance, in March 2019, the U.S. Food and Drug Administration received more than 41,000 adverse event reports — including 366 deaths — associated with surgical staplers and staples for internal use, and that it may require stricter product review of the devices.

Moreover, high cost of surgical stapling devices is also expected to limit the market growth. The cost of the surgical stapling devices ranges from USD$ 75 to US$ 300 which is almost 3X costlier as compare to the high grade suturing materials currently available in the market.

Surgical Stapling Devices Market Report Coverage Report Coverage Details Base Year: 2019 Market Size in 2019: US$ 2,399.0 Mn Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027 Forecast Period 2020 to 2027 CAGR: 7.8% 2027 Value Projection: US$ 4,363.6 Mn Geographies covered: North America: U.S., Canada

U.S., Canada Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Brazil, Argentina, Mexico, Rest of Latin America Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe

Germany, U.K., France, Spain, Italy, Russia, Rest of Europe Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific

China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific Middle East: GCC Countries, Israel, Rest of Middle East

GCC Countries, Israel, Rest of Middle East Africa: North Africa, Central Africa, South Africa Segments covered: By Product Type: Powered Surgical Stapling Device, Manual Surgical Stapling Device.

Powered Surgical Stapling Device, Manual Surgical Stapling Device. By Usage Type: Disposable Surgical Stapling Devices, Reusable Surgical Stapling Devices.

Disposable Surgical Stapling Devices, Reusable Surgical Stapling Devices. By Stapling Type: Straight, Curved, Circular.

Straight, Curved, Circular. By Application: Skin, Digestive Tract, Blood Vessels, Hernia, Lung, Others.

Skin, Digestive Tract, Blood Vessels, Hernia, Lung, Others. By End User: Hospitals, Ambulatory Surgical Centers, Others. Companies covered: Medtronic plc, Johnson & Johnson, 3M Company, Aesculap, Inc. (B. Braun), SeCQure Surgical Corporation, Purple Surgical Holdings Limited, Meril Life Sciences Pvt. Ltd., and Grena Ltd. Growth Drivers: Increasing number of surgical procedures

Approval and launch of new products Restraints & Challenges: High Cost of equipment

Product recall

Global Surgical Stapling Devices Market: Opportunities

R&D in functionality of devices is expected to offer lucrative growth opportunities for players in the global surgical stapling devices market. For instance, in January 2019, a Ethicon funded research stated that Ethicon’s Echelon Flex GST system had a 20% staple-line air leak rate when tested out on pig lungs under modeled physiologic breathing conditions, versus a 44% rate for Medtronic’s Endo Gia with Tri-Staple technology.

Moreover, development of reusable stapling devices is expected to aid in growth of the market.

Statistics:

The global surgical stapling devices market was valued at US$ 2,399.0 Mn in 2019 and is forecast to reach a value of US$ 4,364.6 Mn by 2027 at a CAGR of 7.8% between 2020 and 2027.

Figure 2: Global Surgical Stapling Devices Market Value (US$ Mn), 2016 – 2027

Market Trends/Key Takeaways

Misuse of surgical staplers is on the rise. For instance, according to 13th edition of ECRI Institute’s Top 10 Health Technology Hazards, published in October 2019, surgical stapler misuse is the top health technology hazard, beating out the likes of point-of-care ultrasounds and sterile processing errors.

Increasing concerns regarding injuries from surgical staplers has prompted several regulatory bodies to propose regulatory changes. For instance, in June 2019, The U.S. Food and Drug Administration’s General and Plastic Surgery Devices Panel recommended that surgical staplers for internal use be reclassified to a more highly regulated status.

Global Surgical Stapling Devices Market: Competitive Landscape

Major players operating in the global surgical stapling devices market include, Medtronic plc, Johnson & Johnson, 3M Company, Aesculap, Inc. (B. Braun), SeCQure Surgical Corporation, Purple Surgical Holdings Limited, Meril Life Sciences Pvt. Ltd., and Grena Ltd.

Global Surgical Stapling Devices Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2020, Aesculap, Inc. launched SQ.line surgical instruments portfolio for spine and orthopedic procedures.

Similarly, in March 2018, Purple Surgical Holdings Limited launched laparoscopic and surgical stapling product portfolios at The General Surgery Congress held in Peru.